Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
about
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomesOptimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosisMultiple sclerosis and pregnancy: current considerationsPregnancy, sex and hormonal factors in multiple sclerosis.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Drug therapy for multiple sclerosis.Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.An overview of pregnancy-related issues in patients with multiple sclerosis.Definitive childlessness in women with multiple sclerosis: a multicenter study.Treatment of multiple sclerosis during pregnancy - safety considerations.Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar.Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.Glatiramer acetate during early pregnancy: A prospective cohort study.Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database.The heritage of glatiramer acetate and its use in multiple sclerosis
P2860
Q26776234-B46BD1AA-90BE-4586-8649-2237FA8CEFEBQ26777686-60388897-5B5E-4B7D-A355-3887447BBE19Q26830133-ED5A1AAA-50A9-4674-B93A-46D815708E60Q30354175-83BDDEBE-4473-413D-8CCD-B627ACA9EF68Q31162052-DFB9858E-5D25-4A95-AA1F-7E346E966B4FQ33990246-07A29B1F-C170-4BEE-AAB0-C3B118CA71DEQ36975701-F38948B3-FB75-4554-82D3-C14C71CB2E90Q37459065-45090AFE-80B9-47F5-A43F-36C3E5F086E4Q37547683-129005F3-9008-4D85-9A51-3C70E7368475Q37690636-5F0C0B8E-350F-417A-94F9-C03899FCF9A3Q38085336-B020B1FD-773F-4E02-B8BC-839E431AB60CQ38125249-655608C0-6DB2-405D-B66B-3640752C0F43Q38151555-974BB744-8266-40A1-ABB4-ABF9577DB0FEQ38152977-00002523-6CC7-4F3A-9ED8-7086BF45C308Q38245158-CBA973DB-DD2A-4894-873C-4148569160B8Q38379249-D6A7250F-133C-4777-A8A3-71BAB3E3FABAQ38449394-6A167A0D-C9E3-4422-9A94-491693DA84E7Q38587675-E5A96C56-C6A2-4F34-B36B-F39E48D346A0Q38679960-1F5CFF80-68FE-459B-988D-474121DFB43BQ38883520-0B80E9CC-265A-4F46-9DC8-D31FF41460CDQ39021942-B6EC6E13-EF4E-4B94-95C2-6002FE3A8042Q39964998-3F7EE835-D7F3-404E-8E08-A2DFEABF9651Q40120131-154357BF-DFCB-4436-878A-73EDB7C27A01Q46726626-EE95615F-B6D1-4CA0-BCDD-D02AA6479BD2Q47678330-D6C71BCC-DFD0-44DF-80C7-EB180C8DEF5DQ55086936-45C63D54-4EDB-40FC-8C77-E97FBE7FC2CBQ56804781-024BEBC5-DFA8-49D7-8CA5-8C9A1E3EDB3F
P2860
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@ast
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@en
type
label
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@ast
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@en
prefLabel
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@ast
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@en
P2093
P2860
P50
P356
P1433
P1476
Pregnancy and fetal outcomes a ...... ervational multicentric study.
@en
P2093
Bahia Hakiki
Carlo Pozzilli
Claudio Solaro
Damiano Paolicelli
Elisa Piscolla
Emilio Portaccio
Francesco Patti
Giovanna De Luca
Loredana La Mantia
Lorenzo Razzolini
P2860
P2888
P356
10.1186/1471-2377-12-124
P50
P577
2012-10-22T00:00:00Z
P5875
P6179
1018353869